Anavex Life Sciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Anavex Life Sciences Corp. (AVXL) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2025Sep 2024Sep 2023Sep 2022Sep 2021Sep 2020Sep 2019Sep 2018
Current Assets
Cash and Cash Equivalents102.58132.19151.02149.16152.1129.2522.1922.93
Cash & Short-Term Investments102.58132.19151.02149.16152.1129.2522.1922.93
Accounts Receivable0.812.452.713.199.144.852.641.87
Inventory0.000.000.000.000.000.000.000.00
Other Current Assets0.430.930.650.350.370.000.000.00
Total Current Assets103.82135.57154.39152.71161.6234.5425.3326.05
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.000.000.000.00
Other Non-Current Assets0.000.000.000.000.020.000.000.00
Total Non-Current Assets0.000.000.000.000.020.000.000.15
Total Assets103.82135.57154.39152.71161.6234.5425.3326.21
Current Liabilities
Accounts Payable4.259.634.323.834.747.315.043.88
Accrued Liabilities3.893.317.305.955.610.000.000.00
Deferred Revenue0.810.840.920.440.440.000.000.00
Other Current Liabilities3.890.000.000.000.000.000.000.00
Total Current Liabilities8.9515.3012.5310.2110.807.315.043.88
Non-Current Liabilities
Long-Term Debt0.000.000.000.000.000.000.000.00
Other Non-Current Liabilities3.890.000.000.000.000.000.000.00
Total Non-Current Liabilities3.890.000.000.000.000.000.000.00
Total Liabilities8.9515.3012.5310.2110.807.315.043.88
Stockholders' Equity
Common Stock0.090.090.080.080.080.000.000.00
Retained Earnings-382.45-336.07-293.07-245.56-197.59-159.68-133.40-107.10
Additional Paid-in Capital477.23456.25434.84387.98348.33186.85153.63129.38
Shares Outstanding86.6784.8082.0777.940.000.000.000.00
Total Stockholders' Equity94.87120.26141.85142.49150.8227.2420.2922.32
Total Liabilities & Equity103.82135.57154.39152.71161.6234.5425.3326.21